SCHEMBL695231

SCHEMBL695231

NC(=O)c1cc(-c2cc3c[c]ccc3[nH]2)ccc1F

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A1 P04798 2/20 0.42
CDC7 O00311 5/20 0.36
BRD4 O60885 1/20 0.33
BTK Q06187 2/20 0.33
FFAR1 O14842 1/20 0.33
IKBKB O14920 1/20 0.33
CHUK O15111 1/20 0.33
KDM4E B2RXH2 1/20 0.33
MEN1 O00255 1/20 0.33
NPC1 O15118 1/20 0.33
ALDH1A1 P00352 1/20 0.33
CYP1A2 P05177 1/20 0.33
MAPT P10636 1/20 0.33
CYP2C9 P11712 1/20 0.33
HPGD P15428 1/20 0.33
CYP2C19 P33261 1/20 0.33
CASP3 P42574 1/20 0.33
RAB9A P51151 1/20 0.33
KMT2A Q03164 1/20 0.33
SENP8 Q96LD8 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL694000 0.81 CYP1A1 (0.47) CYP1A1KDM4EMEN1NPC1ALDH1A1
SCHEMBL694188 0.80 RIPK1 (0.50) CASP3SENP8SENP7SENP6ASIC3
SCHEMBL728719 0.79 F2 (0.47) CYP1A1CASP3SENP8SENP7SENP6
SCHEMBL695278 0.76 F2 (0.43) KDM4EMEN1NPC1ALDH1A1MAPT
SCHEMBL694490 0.75 CYP1A1 (0.42) CYP1A1KDM4EMEN1NPC1ALDH1A1
SCHEMBL695386 0.74 CYP1A1 (0.45) CYP1A1KDM4EMEN1NPC1ALDH1A1
SCHEMBL695581 0.74 CYP1A1 (0.40) CYP1A1FFAR1KDM4EMEN1NPC1
SCHEMBL695245 0.73 CYP1A1 (0.38) CYP1A1KDM4EMEN1NPC1ALDH1A1
SCHEMBL694916 0.71 CYP1A1 (0.42) CYP1A1KDM4EMEN1NPC1ALDH1A1
SCHEMBL1202420 0.70 FLT3 (0.42) KDM4ENPC1ALDH1A1MAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2421825-A1 AZETIDINYL DIAMIDES AS MONOACYLGLYCEROL LIPASE INHIBITORS Janssen Pharmaceutica N.V. (BE) 2012-02-29 EP claimed
WO-2010124108-A1 AZETIDINYL DIAMIDES AS MONOACYLGLYCEROL LIPASE INHIBITORS JANSSEN PHARMACEUTICA NV (BE) 2010-10-28 WO claimed
EP-3197450-A1 METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF FIBROSIS INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) 2017-08-02 EP disclosed
WO-2016046130-A1 METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF FIBROSIS INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) 2016-03-31 WO disclosed
EP-2421825-A1 AZETIDINYL DIAMIDES AS MONOACYLGLYCEROL LIPASE INHIBITORS Janssen Pharmaceutica N.V. (BE) 2012-02-29 EP disclosed
WO-2010124108-A1 AZETIDINYL DIAMIDES AS MONOACYLGLYCEROL LIPASE INHIBITORS JANSSEN PHARMACEUTICA NV (BE) 2010-10-28 WO disclosed